Original article by Natasha Robinson
The Australian Financial Review – Page: 1 & 5 : 20-May-20
Australia-based Q-Pharm will shortly commence a phase one clinical trial of a coronavirus vaccine that is being developed by US biopharmaceutical group Novavax. Some 131 people in Melbourne and Brisbane have volunteered to participate in the clinical trial. Q-Pharm will also undertake phase 1 clinical trials of a potential vaccine that being developed by the University of Queensland. Meanwhile, the Walter & Eliza Hall Institute of Medical Research will commence a clinical trial of antimalarial drug hydroxychloroquine.
Q-PHARM PTY LTD, UNIVERSITY OF QUEENSLAND, WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH